In conclusion, GLP-1 receptor agonists represent a major advance in metabolic medicine and, based on current evidence, offer collateral benefits for male reproductive and sexual health rather than harm
YP05002: A Growing Contender in the GLP-1 Space YP05002 and related oral GLP-1R agonists were fully developed by Yao Pharma and carry proprietary intellectual property rights
Older Adults As we age, the bodys ability to absorb B12 from food decreases, making supplementation essential
Mutation-agnostic detection of colorectal cancer-specific cell-free DNA using targeted methylation sequencing
When administered under medical supervision with safety screening, common side effects are mild, including temporary tenderness at the IV site and occasional mild nausea
The guidelines also prioritise obesity medications like semaglutide and tirzepatide for their proven efficacy in preventing major adverse cardiovascular events and improving metabolic health